World Health Summit 2016

All panel discussions, held at the "Europasaal" of the Federal Foreign Office in Berlin, are available as video-streams below.

Startup Pitches

- Care Across (Greece)
- Cold Plasmatech (Germany)
- evivecare (Germany)
- Glasschair (Germany)
- iFeel Healthy (Israel)
- midge medical UG (Germany)
- OneWorldDoctors (Germany)
- Pelvifly (Poland)
- Symptoma (Austria)
- WinSenga (Uganda)

Oct. 9: Governance for Health

- Cobus de Swardt (Managing Director, Transparency International, Germany)
- Agnès Couffinhal (Senior Economist, Organisation for Economic Cooperation and Development, France)
- Andrew Daniels (Head, Anti-bribery & Corruption Centre of Excellence, GlaxoSmithKline Pharmaceuticals, UK)
- Suzanne Hill (Director, Essential Medicines and Health Products, World Health Organization, Switzerland)
- Tewodros Melesse (Director-General, The International Planned Parenthood Federation, UK)

Oct. 9: Noncommunicable Diseases

- Volkmar Falk (Medical Director, German Heart Institute Berlin, Germany)
- Charles Yankah (President, African Cultural Institute, Germany)
- Fiona Adshead (Chief Officer, Wellbeing and Public Health, BUPA, UK)
- Ann Aerts (Director, Novartis Foundation, Switzerland)
- Oleg Chestnov (WHO Assistant Director-General, Noncommunicable Diseases and Mental Health, Switzerland)
- Jayasree Iyer (Executive Director, Access to Medicine Foundation, Netherlands)
- Francis E. Smit (Head, Cardiothoracic Surgery, University of the Free State, South Africa)

Oct. 9: Infectious Deseases

- Peter J. Hotez (President, Sabin Vaccine Institute, USA)
- Christian Bréchot (President, Institut Pasteur, France)
- Stefan Kaufmann (Director, Max Planck Institute for Infection Biology, Germany)
- Hon. Suresh Kumar (Head, Government Relations US ad interim, Sanofi, USA)
- Joy Phumaphi (Executive Secretary, African Leaders Malaria Alliance, Botswana)
- Rolf Zinkernagel (Professor Emeritus, Experimental Immunology, University Hospital Zurich, Switzerland)

Oct 9: Global Health Security

- Ambassador Wolfgang Ischinger (Chairman, Munich Security Conference Foundation, Germany)
- Sarbani Chakraborty (Head of Global Health Policy, Government Affairs and Policy, Merck Group, Germany)
- Xavier Crespin (Director-General, West African Health Organization, Burkina Faso)
- Victor J. Dzau (President, National Academy of Medicine, USA)

Oct 10: Universal Health Coverage

- Ilona Kickbusch (Director, The Graduate Institute of International and Development Studies, Switzerland)
- Michael Rabbow (Senior Advisor, E&P Focus Africa Consulting GmbH, Germany)
- Rosalinda Baldoz (Former Secretary, Labor and Employment, Government of the Philippines, Philippines)
- Manuel Delgado (Secretary of State of Health, Ministry of Health of Portugal)
- Ali Jafarian (Chancellor, Tehran University of Medical Sciences, Iran)
- Justin P. McCarthy (Senior Vice-President, Global Policy and International Public Affairs, Pfizer Inc., USA)
- Matshidiso Rebecca Moeti (WHO Regional Director for Africa, Botswana)
- Heiko Warnken (Head, Health, Population Policy and Social Protection, Federal Ministry for Ecconomic Cooperation and Development, Germany)

Oct 10: Planetary Health

- Andrew Haines (Professor, London School of Hygiene & Tropical Medicine UK)
- Anthony Capon (Director, International Institute for Global Health, United Nations University, Malaysia)
- Samuel S. Myers (Director, Planetary Health Alliance, Harvard T.H. Chan School of Public Health, USA)
- Montira Pongsiri (HEAL Director, Wildlife Conservation Society, USA)
- Robert Sebbag (Vice-President, Access to Medicines, Sanofi Aventis, France)

Oct 10: The Contribution of Biologic Medicines to Public Health

- Janis Bernat (Associate Director, Biotherapeutics & Scientific Affairs, IFPMA, Switzerland)
- Matthias Wienold (Board Treasurer, International Alliance of Patients Organizations, UK)
- Paul Declerck (Dean, Faculty of Pharmaceutical Sciences, KU Leuven University, Belgium)
- Georg Marckmann (President, Institute for Ethic, History and Theory in Practice, LMU Munich, Germany)
- Axel C. Mühlbacher (Professor, Hochschule Neubrandenburg, Germany)
- Brendan Shaw (Assistant Director General, IFPMA, Switzerland)
- Durhane Wong-Rieger (Past Chair, International Alliance of Patients' Organizations, UK)

Oct 11: Value in Healthcare

- Stefan Larsson (Senior Partner & Managing Director, The Boston Consulting Group, Sweden)
- Olivier Oullier (Head, Strategy, Global Health and Healthcare, World Economic Forum, Switzerland)
- Eric Hans Eddes (Director, Dutch Institute for Clinical Auditing, Netherlands)
- Norbert Hauser (Chairman of the Board, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland)
- Paul Hudson (CEO, Novartis Pharmaceuticals, Switzerland)
- Jan Kimpen (Chief Medical Officer, Royal Philips NV, Netherlands)
- Christina Rångemark Åkerman (President, ICHOM, USA)

Oct 11: Antimicrobial Resistance

- Lothar Wieler (President, Robert Koch Institute, Germany)
- Helge Braun (Minister of State, Federal Chancellery, Germany)
- Peter Hammann (Head, Therapeutic Area Infectious Diseases, Sanofi-Aventis, Germany)
- Matthiessen-Guyader (Head of Fighting Infectious Diseases and Global Epidemics, Research and Innovation, European Commission, Belgium)
- Jim O'Neill (Chairman of the Board, The Review on Antimicrobial Resistance, UK)
- Jaqueline Shea (CEO, Aeras, USA)
- Marc Sprenger (Director, Antimicrobial Resistance Secretariat, World Health Organization, Switzerland)
- Bernd-Alois Tenhagen (Private Lecturer, Biological Safety, Federal Institute for Risk Assessment, Germany)